Company Oncoinovation Srl with Fiscal Code 36375206
recorded a turnover of 2024 of
233.919,
with a net profit of
92.547
and having an average number of employees of
4.
The company operates in the field of Activităţi de asistenţă spitalicească having the NACE code 8610.
Sales - Ron
Sales, Profit, Employees, Total Income, Financial Results -
Oncoinovation Srl
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Sales - EUR
-
-
21.974
10.912
56.794
94.422
122.813
118.260
174.194
233.919
Total Income - EUR
-
-
21.974
10.955
56.794
94.422
122.813
118.487
175.234
234.897
Total Expenses - EUR
-
-
44
111
36.903
72.786
78.771
89.525
101.026
124.036
Gross Profit/Loss - EUR
-
-
21.929
10.844
19.891
21.635
44.041
28.962
74.208
110.861
Net Profit/Loss - EUR
-
-
21.270
10.516
19.323
20.769
42.813
27.777
72.455
92.547
Employees
-
-
0
0
3
3
3
3
3
4
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded.
In the last year of activity, the sales increased by 35.0%, from 174.194 euro in the year 2023, to 233.919 euro in 2024.
The Net Profit increased by 20.497 euro, from 72.455 euro in 2023, to 92.547 in the last year.
Check the financial reports for the company - Oncoinovation Srl
Financial Rating - ONCOINOVATION SRL
See the company's note based on the submitted financial data, relative to the industry of which it is a part.
Financial Rating
Payment Limits - Oncoinovation Srl
See the company's payment capacity for situations in which you conclude contracts with payment terms.
Check Payment Limits
Prob. of insolvency - Oncoinovation Srl
It determines the risk of insolvency based on the submitted accounting balance.
Insolvency Probability
Financial Reports - Oncoinovation Srl
Check all the financial reports of the company and know the risks in collaboration with it.
Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of
64.506 euro in 2024 which includes Inventories of
0 euro, Receivables of
50.258 euro and cash availability of
14.247 euro.
The company's Equity was valued at
92.620 euro, while total Liabilities amounted to
10.377 euro.
Equity increased by 20.497 euro, from 72.528 euro in 2023, to 92.620 in 2024.
Similar services useful for checking companies and business development.
SellNet
Get the contact details for any company and get in touch with it.
Sectoral Studies
Knows the market and develops its own development strategies according to sectorial data.
Databases
Export in excel files the data of the companies selected according to the desired criteria.
Import - Export
Find importers and exporters according to the type of activity and the countries in which they carry it out.
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.
Comments - Oncoinovation Srl